Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Izopet

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Annales Pharmaceutiques Francaises|February 4, 2018
[HEV and transfusion-recipient risk]J Izopet
Virologie (Montrouge, France)|October 23, 2021
[Can treatment interruption strategies improve the management of HIV infection ?]J Izopet
Medecine Et Maladies Infectieuses|October 20, 2009
[Originality of entry inhibitors]J Izopet
Medecine Et Maladies Infectieuses|April 2, 2005
[Hepatitis B virus resistance]J Izopet
Gastroenterologie Clinique Et Biologique|January 1, 1996
[Does a healthy carrier of hepatitis C exist?]J L Payen, J Izopet
Public Health|June 2, 2020
We must not forget the most disadvantaged people facing the COVID-19 crisisJ M Mansuy, J Izopet
Virologie (Montrouge, France)|September 22, 2022
[Genotypic recombination and hepatitis C virus]F Legrand-Abravanel, J Izopet
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 11, 2011
No reactivation of hepatitis e virus after kidney retransplantationN Kamar, J Izopet, L Rostaing
Nephrologie|June 20, 2003
[Hepatitis C infection among patients receiving hemodialysis]N Kamar, J Izopet, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2016
When Should Ribavirin Be Started to Treat Hepatitis E Virus Infection in Transplant Patients?N Kamar, O Marion, J Izopet
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Annales Pharmaceutiques Francaises|February 4, 2018
[HEV and transfusion-recipient risk]J Izopet
Virologie (Montrouge, France)|October 23, 2021
[Can treatment interruption strategies improve the management of HIV infection ?]J Izopet
Medecine Et Maladies Infectieuses|October 20, 2009
[Originality of entry inhibitors]J Izopet
Medecine Et Maladies Infectieuses|April 2, 2005
[Hepatitis B virus resistance]J Izopet
Gastroenterologie Clinique Et Biologique|January 1, 1996
[Does a healthy carrier of hepatitis C exist?]J L Payen, J Izopet
Public Health|June 2, 2020
We must not forget the most disadvantaged people facing the COVID-19 crisisJ M Mansuy, J Izopet
Virologie (Montrouge, France)|September 22, 2022
[Genotypic recombination and hepatitis C virus]F Legrand-Abravanel, J Izopet
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 11, 2011
No reactivation of hepatitis e virus after kidney retransplantationN Kamar, J Izopet, L Rostaing
Nephrologie|June 20, 2003
[Hepatitis C infection among patients receiving hemodialysis]N Kamar, J Izopet, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2016
When Should Ribavirin Be Started to Treat Hepatitis E Virus Infection in Transplant Patients?N Kamar, O Marion, J Izopet
Pageof 16